Brief: Sangamo Therapeutics Q1 EPS USD -0.14 Vs. IBES Estimate USD -0.13

Sangamo Therapeutics

12/05/2025 23:26

May 12 (Reuters) - Sangamo Therapeutics Q1 operating income USD -29.628 million.

Q1 net income USD -30.597 million

Q1 operating expenses USD 36.1 million

Q1 revenue USD 6.437 million vs. IBES estimate USD 7.42 million

Q1 adjusted operating expenses USD 26 million